Table of Content


Introduction
Graft Versus Host Disease (GVHD) - Overview
Graft Versus Host Disease (GVHD) - Therapeutics Development
Graft Versus Host Disease (GVHD) - Therapeutics Assessment
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development
Graft Versus Host Disease (GVHD) - Drug Profiles
Graft Versus Host Disease (GVHD) - Dormant Projects
Graft Versus Host Disease (GVHD) - Discontinued Products
Graft Versus Host Disease (GVHD) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for Graft Versus Host Disease (GVHD), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Graft Versus Host Disease (GVHD), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Graft Versus Host Disease (GVHD) - Pipeline by 9 Meters Biopharma Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Abbisko Therapeutics Co Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by AbbVie Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Accro BioScience (Suzhou) Co Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Actitrexx GmbH, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Adienne Pharma & Biotech SA, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Agenus Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Alphamab Oncology, 2021
Graft Versus Host Disease (GVHD) - Pipeline by AltruBio Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Amgen Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by AnaMar AB, 2021
Graft Versus Host Disease (GVHD) - Pipeline by AnaptysBio Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by ASC Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by AstraZeneca Plc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Athersys Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Athos Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Autolus Therapeutics Plc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Avalon GloboCare Corp, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Bellicum Pharmaceuticals Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Biocon Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Biogen Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by BioIncept LLC, 2021
Graft Versus Host Disease (GVHD) - Pipeline by BioTheryX Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by BlueRock Therapeutics LLC, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Boryung ViGenCell Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Bristol Myers Squibb Co, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Capricor Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellect Biotechnology Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellective BioTherapy Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellenkos Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellestia Biotech AG, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellix Bio Pvt Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by CELLnLIFE Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Celltrion Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Cellvation Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by CheckPoint Immunology Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Claritas Pharmaceuticals Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Kamada Pharmaceuticals, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Kiniksa Pharmaceuticals Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Kymab Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by MaaT Pharma, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Machavert Pharmaceuticals LLC, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Magenta Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Mallinckrodt Plc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Medexus Pharmaceuticals Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Medicenna Therapeutics Corp, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Mediolanum farmaceutici SpA, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Medsenic SAS, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Merck & Co Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Mereo Biopharma Group Plc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Mesoblast Ltd, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Millennium Pharmaceuticals Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by MitoImmune Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by NapaJen Pharma Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Neovii Pharmaceuticals AG, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Nurix Therapeutics Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by OncoC4 Inc, 2021
Graft Versus Host Disease (GVHD) - Pipeline by Orca Biosystems Inc, 2021
Graft Versus Host Disease (GVHD) - Dormant Projects, 2021
Graft Versus Host Disease (GVHD) - Discontinued Products, 2021